Diagnos Laboratorium Utama Tbk. vs King Tire Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while King Tire Indonesia Tbk. trades at Rp112 (market cap 389.83B, 433.9K 24h volume). The key difference: King Tire Indonesia Tbk. is the larger of the two by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 433.9K). Which is the better fit depends on your goals.
| DGNS | TYRE | |
|---|---|---|
Market Cap | 310.75B | 389.83B |
Volume | 963.6K | 433.9K |
Lot | 9.64K | 4.34K |
Turnover | 217.67M | 48.15M |
Average Price | 225.89 | 110.98 |
Value | 217.67M | 48.15M |
Indicative Equilibrium Price | 226 | 112 |
Indicative Equilibrium Volume | 1K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT King Tire Indonesia Tbk (the Company) was established on August 2, 2010 based on Notarial Deed No. 01 of Humberg Lie, S.H., S.E., M.Kn., notary in Jakarta. The Company started its commercial operations in 2011. The Companys immediate parent entity is PT Kingland Investindo Nusantara. The controlling interest of the Company is owned by an individual namely Harris Muliawan.
Read more on TYRE →